| Literature DB >> 36233244 |
Litao Niu1,2, Nigora Rustamova1,2,3, Huxia Ning1,2, Paiziliya Paerhati1,2, Chunfang Lu1,2, Abulimiti Yili1,2.
Abstract
Secondary metabolites produced by endophytic fungi are an important source of biologically active compounds. The current research was focused on the biological activities of ethyl acetate extracts of fungi, isolated and identified from Vernonia anthelmintica flowers for the first time. In addition, an investigation of the non-polar chemical composition of dichloromethane-ethyl acetate extracts of the most active fungal strain was carried out. The isolates included Ovatospora senegalensis NR-03, Chaetomium globosum NR-04, Thielavia subthermophila NR-06, Aspergillus calidoustus NR-10, Aspergillus keveii XJF-23 and Aspergillus terreus XJF-3 species. Strains were identified by 18S rRNA gene sequencing methods and were registered in GenBank. Crude extracts of the fungi displayed in vitro biological activities, including antimicrobial and cytotoxic activities. A melanin content assay was performed on murine B16 cells. An ethyl acetate extract of O. senegalensis NR-03 showed high anticancer and antimicrobial activity; therefore, we also studied the non-polar chemical composition of the dichloromethane-ethyl acetate fraction and identified 52 non-polar compounds with the different medium. This investigation discovered that the secondary metabolites of the total extract of endophytic fungi could be a potential source of alternative natural antimicrobial, cytotoxic and melanin synthesis activity in their host plant, and the isolation of bioactive metabolites may provide a lead to new compounds of pharmaceutical significance.Entities:
Keywords: Vernonia anthelmintica flowers; biological activities; endophytic fungi; non-polar chemical composition
Mesh:
Substances:
Year: 2022 PMID: 36233244 PMCID: PMC9569571 DOI: 10.3390/ijms231911935
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Isolated fungal strains from the flowers of the medicinal plant V. anthelmintica.
Figure 2The phylogenetic tree of endophytic fungi isolated from V. anthelmintica, with the closest relatives registered in GenBank of NCBI.
Sequence similarities of endophyte fungi isolated from aerial parts of V. anthelmintica with sequences registered in GenBank.
| Isolated Strains Sequences | Closest Match among Bacteria (18S rRNA Genes) (GenBank) | |||
|---|---|---|---|---|
| Strains | Accession | Species | Source | ID% |
| NR-03 | MW996742 |
| flower | 100 |
| NR-04 | MW996743 |
| flower | 99.04 |
| NR-06 | MW996745 |
| flower | 100 |
| NR-10 | MW996749 |
| flower | 100 |
| XJF-23 | MW881461 |
| flower | 99.82 |
| XJF-3 | MW881454 |
| flower | 99.94 |
Antimicrobial activity (ZOI) of endophytic fungi associated with medicinal plant V. anthelmintica flowers.
| Sample | Sample | Sample | |||
|---|---|---|---|---|---|
| Ampicillin | 312.5 μg/mL | 20 | - | 11 | - |
| Ampicillin | 4.44 μg/mL | 20 | - | - | 18.5 |
| Amphotericin B | 5 μg/mL | 20 | 12 | - | - |
| 50 μg/mL | 20 | 7.5 | 26 | 19 | |
| 50 μg/mL | 20 | 12 | - | 20 | |
| 50 μg/mL | 20 | 9.5 | 9 | 11 | |
| 50 μg/mL | 20 | 10 | 13 | 15 | |
| 50 μg/mL | 20 | 8 | 10 | 15 | |
| 50 μg/mL | 20 | 10 | 11 | 16 |
Determination of minimum inhibitory (MIC) concentration of endophytic fungi associated with medicinal plant V. anthelmintica flowers.
| Sample |
|
|
|
|---|---|---|---|
| MIC | MIC | MIC | |
| ND | 2000 | 62.5 | |
| 31.25 | ND | 125 | |
| ND | ND | ND | |
| ND | 125 | ND | |
| ND | 250 | ND | |
| 250 | 62.5 | 250 | |
| Ampicillin 100 mg/mL | - | 0.98 | 62.5 |
| Amphotericin B 50 mg/mL | 0.98 | - | - |
Stimulation of melanin content of B16 cells by total crude extracts of the endophytic fungi.
| Sample | Concentration | Intracellular Melanin Content (% of Control) |
|---|---|---|
| Control | 2µL-DMSO | 100.00 |
| 8-MOP | 50μM | 123.34 |
| 50μg/mL | 154.49 | |
| 50μg/mL | 171.58 | |
| 50μg/mL | 156.27 | |
| 50μg/mL | 193.31 | |
| 50μg/mL | 205.35 | |
| 50μg/mL | 208.46 |
Figure 3(A) Stimulation of melanin content of B16 cells by secondary metabolites of crude extract of the fungi; (B) melanin content activity of different concentration; (C) tyrosinase activity of different concentration. Note: * compared to the blank control group (DMSO), p < 0.05; ** compared to the blank control group (DMSO), *** p < 0.001 compared with the blank control group (DMSO); p < 0.01 **** compared to the blank control group (DMSO), p < 0.0001.
Effect of crude extracts of endophytic fungi on melanin production and tyrosinase activity in B16 cells.
| Sample | Concentration | Intracellular Melanin Content | Tyrosinase Activity |
|---|---|---|---|
| Control | DMSO | 100.00 | 100.00 |
| 8-MOP | 50 µM | 125.52 | 124.8 |
| 5 µM | 137.91 | 113.12 | |
| 10 µM | 162.17 | 130.02 | |
| 50 µM | 197.98 | 146.63 | |
| 5 µM | 96.57 | 95.05 | |
| 10 µM | 161.18 | 129.02 | |
| 50 µM | 204.02 | 151.63 | |
| 5 µM | 133.24 | 114.06 | |
| 10 µM | 167.85 | 140.06 | |
| 50 µM | 207.12 | 146.63 |
Cytotoxic activity of total extracts obtained from fungal endophytes on human cancer cell lines HT-29, MCF-7 and HeLa (n = 3).
| Samples | Cell Lines | ||
|---|---|---|---|
| IC50 (μg/mL) | |||
| HT-29 | MCF-7 | HeLa | |
| 0.10 μg/mL ± 0.004 | Not active | 0.09 μg/mL ± 0.005 | |
| 32.41 μg/mL ± 2.20 | Not active | 29.38 μg/mL ± 1.27 | |
| 3.85 μg/mL ± 0.15 | 9.99 μg/mL ± 0.69 | 5.89 μg/mL ± 0.35 | |
| 16.44 μg/mL ± 0.85 | 19.55 μg/mL ± 1.03 | 13.59 μg/mL ± 0.63 | |
| 31.37 μg/mL ± 1.82 | Not active | 17.81 μg/mL ± 0.78 | |
| Not active | Not active | 0.10 μg/mL ± 0.005 | |
| DOX | 0.82 μg/mL ± 0.041 | 0.17 μg/mL ± 0.006 | 0.11 μg/mL ± 0.005 |
Figure 4Optimization of incubation time (A) and different medium for production secondary metabolites (B) by leading endophytic fungus of O. senegalensis NR-03.
Figure 5Microscopical view of O. senegalensis NR-03 conidial heads ×1000, ×750 (A,B) and (C,D) hyphae ×500, mycelium ×1000 and conidiophore.
Figure 6Analytical HPLC chromatograms of the crude extract of endophytic fungus from different medium. Recorded at 254 nm and performed using a waters column 412 and acetonitrile, 0.1% acidified water with formic acid as mobile phase. B—PBG; C—Czapeck-Dox; D—BEB; E—YPD; F—SAB; G—MEB; H—PDB.
The chemical composition of dichloromethane-ethyl acetate of the O. senegalensis NR-03.
| № | Composition | tR (min) | Relative Peak Area % | ||||||
|---|---|---|---|---|---|---|---|---|---|
| BEB | SAB | YPD | MEB | PBG | CDM | PDB | |||
| 1 | 3-Methyl-butanoic acid | 3.418 | - | - | - | 1.40 | - | - | - |
| 2 | 2-Methyl-butanoic acid | 3.520 | - | - | - | 0.48 | - | - | 0.78 |
| 3 | p-Xylene | 3.741 | - | - | - | - | - | 1.71 | - |
| 4 | 3-methyl-1,2-cyclopentanedione | 5.848 | - | - | - | - | - | - | 1.41 |
| 5 | 2-Methyl-phenol | 6.247 | - | 0.21 | - | 0.12 | - | - | 0.22 |
| 6 | p-Cresol | 6.553 | - | 1.96 | - | 0.28 | - | - | - |
| 7 | Tetramethyl-pyrazine | 6.714 | - | - | 0.26 | - | - | - | - |
| 8 | Maltol | 7.105 | - | - | - | 0.57 | - | - | - |
| 9 | Phenylethyl alcohol | 7.139 | - | - | 0.13 | - | - | - | - |
| 10 | N-(3-Methylbutyl)acetamide | 7.402 | - | - | 0.16 | - | - | - | - |
| 11 | Benzeneacetic acid | 9.136 | - | 3.02 | - | - | - | - | 1.00 |
| 12 | Indole | 9.756 | - | - | 0.56 | - | - | - | - |
| 13 | Orcinol | 10.801 | - | 1.66 | - | 1.11 | - | - | - |
| 14 | 4-Hydroxy-2-methylbenzaldehyde | 11.157 | - | - | - | - | - | - | 1.11 |
| 15 | 3,4-Bis(methylene)-cyclopentanone | 11.480 | - | - | 0.36 | - | - | - | - |
| 16 | 4-Hydroxy-benzeneethanol | 11.489 | - | - | - | 0.99 | - | - | - |
| 17 | 3-Ethyl-2,5-dimethyl-pyrazine | 11.795 | - | - | 0.53 | - | - | - | - |
| 18 | Terrein | 11.948 | - | - | 0.92 | - | - | - | 33.71 |
| 19 | 3,5-Diethyl-2-methyl-pyrazine | 12.474 | - | - | 0.30 | - | - | - | - |
| 20 | Dimethyl(3-methylphenoxy)ethoxy-silane | 12.525 | - | - | - | - | - | - | 1.09 |
| 21 | N-(2-Phenylethyl)-acetamide | 12.542 | - | - | 0.76 | - | - | - | - |
| 22 | Thymine | 13.587 | - | - | 1.13 | - | - | - | - |
| 23 | 3-Mercaptobenzoic acid, S-methyl-, methyl ester | 14.258 | - | - | - | 0.44 | - | - | - |
| 24 | Tetradecanoic acid | 15.278 | - | - | - | - | - | - | 0.22 |
| 25 | Hexahydro-pyrrolo[1,2-a]pyrazine-1,4-dione | 15.337 | - | - | 0.41 | - | - | - | - |
| 26 | Pentadecanoic acid | 16.008 | - | 0.17 | - | - | - | - | 1.10 |
| 27 | N,N-Dimethyl-1H-purin-6-amine | 16.153 | - | - | 0.30 | - | - | - | - |
| 28 | N-Acetyltyramine | 16.280 | - | - | 2.21 | - | - | - | - |
| 29 | Hexadecanoic acid, methyl ester | 17.223 | - | - | - | - | - | - | 1.94 |
| 30 | Hexahydro-3-(2-methylpropyl)-pyrrolo[1,2-a]pyrazine-1,4-dione | 17.393 | 36.59 | - | - | - | - | 7.90 | - |
| 31 | 3,4-dihydro-6,8-dihydroxy-3-methyl-1H-2-benzopyran-1-one | 17.546 | - | - | - | 0.44 | - | - | - |
| 32 | n-Hexadecanoic acid | 17.656 | - | - | - | - | - | - | 0.60 |
| 33 | Eicosamethyl-cyclodecasiloxane, | 17.903 | - | - | - | - | - | - | 0.31 |
| 34 | Hexadecanoic acid, ethyl ester | 18.081 | - | - | - | - | - | - | 0.34 |
| 35 | 9,12-Octadecadienoic acid (Z,Z)-, methyl ester | 19.449 | - | - | - | - | - | - | 6.39 |
| 36 | (E)-9-Octadecenoic acid, methyl ester | 19.525 | - | - | - | - | - | - | 6.15 |
| 37 | Methyl stearate | 19.848 | - | - | - | - | - | - | 0.87 |
| 38 | Linoleic acid ethyl ester | 20.358 | - | - | - | - | - | - | 0.78 |
| 39 | (E)-9-Octadecenoic acid ethyl ester | 20.434 | - | - | - | - | - | - | 0.62 |
| 40 | N-[2-(1H-indol-3-yl)ethyl]-acetamide | 20.859 | - | - | 0.76 | - | - | - | - |
| 41 | 3-Benzyl-6-isopropyl-2,5-piperazinedione | 21.845 | - | - | 0.22 | - | - | - | - |
| 42 | Octadecamethyl-cyclononasiloxane | 21.989 | - | - | - | - | - | - | 0.36 |
| 43 | Hexadecane | 22.244 | - | - | - | - | - | 3.05 | |
| 44 | Hexahydro-3-(phenylmethyl)-pyrrolo[1,2-a]pyrazine-1,4-dione | 22.915 | 14.44 | 1.47 | 21.64 | - | 14.47 | 18.13 | 0.56 |
| 45 | Tetracosane | 23.671 | - | - | - | - | - | 4.89 | - |
| 46 | Eicosane | 25.098 | - | - | - | - | - | 5.60 | - |
| 47 | Rosenonolactone | 26.152 | - | - | - | - | - | - | 2.11 |
| 48 | (5.beta.)-chol-7-ene | 27.129 | - | - | - | 0.81 | - | - | - |
| 49 | 1,8-dihydroxy-3-methoxy-6-methyl-9,10 anthracenedione | 27.256 | - | - | - | 0.22 | - | - | - |
| 50 | 3,4-dihydro-3-hydroxy-2,2-dimethyl-, (R)-2H-naphtho[1,2-b]pyran-5,6-dione | 31.087 | - | - | - | - | 0.83 | - | - |
| 51 | Simvastatin | 31.391 | - | - | - | 14.38 | 15.68 | - | 1.60 |
| 52 | Lovastatin | 34.307 | - | - | - | - | - | - | 0.67 |